Sign up for the QMED & MD+DI Daily newsletter.
Siemens Healthineers Snag FDA Clearance for Syngo Virtual Cockpit
The software offers a private, secure communication platform for real-time image visualization, acquisition, and collaboration between healthcare practitioners across multiple physical sites.
January 25, 2024
1 Min Read
Image courtesy of Siemens Healthineers
Siemens Healthineers recently announced the FDA clearance of its Syngo Virtual Cockpit which, according to the company, is the first and only multi-vender remote scanning software to receive FDA clearance as a medical product.
Syngo is a private, secure communication platform for real-time image visualization, acquisition, and collaboration between healthcare practitioners across multiple physical sites. Regardless of location, the virtual cockpit enables users to connect to computed tomography (CT), magnetic resonance (MR), positron emission tomography (PET), single-photon emission CT (SPECT), PET/CT, SPECT/CT, and PET/MR scanners from Siemens and other vendors.
Radiologic technologists can use Syngo to connect with live audio, video, and chat functionalities to conduct scans or provide support for up to three different remote scanners simultaneously. Utilizing the software in this way, according to the company, allows providers to better address the ongoing technologist shortage as well as standardize care and consistency across the health system.
In addition to enabling offsite scanning and support, Syngo can also be used for on-the-job training at remote facilities.
“With this FDA clearance for Syngo Virtual Cockpit, Siemens Healthineers proudly offers our customers the first and only multi-vendor, multi-modality, FDA-cleared solution for remote assistance scanning,” said Peter Shen, head of digital and automation at Siemens Healthineers North America, in a press release. “This FDA clearance means that our customers can use Syngo Virtual Cockpit for their remote scanning operations with even more confidence that they are using a proven solution — one that prioritizes patient safety and convenience while also addressing operational and staffing challenges.”
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read